ClearPoint Neuro CEO exercises 12,517 options
ClearPoint Neuro’s CEO exercised stock options for 12,517 shares at $3.47, increasing his direct and trust holdings with no shares sold.
Rhea-AI Filing Summary
ClearPoint Neuro, Inc. (CLPT) CEO and President Joseph Burnett exercised 12,517 stock options on September 2, 2026 at an exercise price of $3.47 per share, paying the exercise price in cash. He received 12,517 shares of common stock and, according to the company disclosure, no shares were sold in connection with this transaction.
After the exercise, Burnett holds 130,720 shares of ClearPoint Neuro common stock directly and 191,388 shares indirectly through the Joseph M. Burnett Trust dated October 20, 2022, where he is trustee. The options exercised were part of a grant dated August 15, 2019 that vests over three years.
Positive
- None.
Negative
- None.
Insider Trade Summary
12,517 shares exercised/converted
Exercise
3 txns
Insider
BURNETT JOSEPH
Role
CEO and President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) F1, F3 | 12,517 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 12,517 | $3.47 | $43K |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Stock Options (right to buy) — 61,887 contracts (Direct);
Common Stock — 130,720 shares (Direct);
Common Stock — 191,388 shares (Indirect, See footnote)
Footnotes (3)
- F1. Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.
- F2. These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
- F3. The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is August 15, 2019.
Key Figures
Options exercised: 12,517 options
Exercise price: $3.47 per share
Shares acquired from exercise: 12,517 shares
+4 more
7 metrics
Options exercised
12,517 options
Stock options exercised on September 2, 2026
Exercise price
$3.47 per share
Exercise price for 12,517 stock options
Shares acquired from exercise
12,517 shares
Common stock received upon option exercise
Direct holdings after transaction
130,720 shares
Direct ClearPoint Neuro common stock held by Joseph Burnett after exercise
Indirect holdings via trust
191,388 shares
Shares held by the Joseph M. Burnett Trust dated 10/20/2022
Option expiration date
August 15, 2029
Expiration of the exercised stock options grant
Option grant date
August 15, 2019
Grant date of the stock options exercised
Key Terms
Stock Options (right to buy), exercise price, indirectly, expiration date, +1 more
5 terms
Stock Options (right to buy) financial
"The security involved was described as Stock Options (right to buy)."
exercise price financial
"Mr. Burnett paid the exercise price for the options in cash."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
indirectly financial
"These shares are owned directly by the Joseph M. Burnett Trust and indirectly by Joseph M. Burnett."
expiration date financial
"The option has an expiration date of August 15, 2029."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The shares subject to this option vest as follows under a three-year schedule."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did CLPT CEO Joseph Burnett report in this Form 4?
He exercised 12,517 stock options for ClearPoint Neuro (CLPT) on September 2, 2026 at an exercise price of $3.47 per share, receiving 12,517 common shares. The disclosure states he paid the exercise price in cash and no shares were sold.
Was any ClearPoint Neuro (CLPT) stock sold in this Form 4 transaction?
No. A footnote states that Joseph Burnett paid the option exercise price in cash, held all shares received upon exercise, and that no shares of stock were sold in connection with this transaction.
What were the terms of the CLPT options exercised by Joseph Burnett?
The exercised options covered 12,517 shares of ClearPoint Neuro common stock at an exercise price of $3.47 per share and have an expiration date of August 15, 2029. They relate to a grant dated August 15, 2019 with a three-year vesting schedule.
How are Joseph Burnett’s indirect CLPT holdings structured?
A footnote states that 191,388 shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph Burnett as trustee of the trust, reflecting his indirect ownership of those ClearPoint Neuro shares.
Were the CLPT transactions made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and there is no footnote indicating that the option exercise or related share acquisition was made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
